72 related articles for article (PubMed ID: 1746909)
1. Expression analysis of EGF-R and TGFa in human ovarian carcinomas.
Bauknecht T; Kommoss F; Birmelin G; von Kleist S; Kohler M; Pfleiderer A
Anticancer Res; 1991; 11(4):1523-8. PubMed ID: 1746909
[TBL] [Abstract][Full Text] [Related]
2. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
3. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFA) expression in different endometrial cancers.
Jasonni VM; Amadori A; Santini D; Ceccarelli C; Naldi S; Flamigni C
Anticancer Res; 1995; 15(4):1327-32. PubMed ID: 7654016
[TBL] [Abstract][Full Text] [Related]
6. Oncogene and growth factor expression in ovarian cancer.
Kommoss F; Bauknecht T; Birmelin G; Kohler M; Tesch H; Pfleiderer A
Acta Obstet Gynecol Scand Suppl; 1992; 155():19-24. PubMed ID: 1502888
[TBL] [Abstract][Full Text] [Related]
7. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.
Radinsky R; Risin S; Fan D; Dong Z; Bielenberg D; Bucana CD; Fidler IJ
Clin Cancer Res; 1995 Jan; 1(1):19-31. PubMed ID: 9815883
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
9. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
10. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
11. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.
Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G
Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442
[TBL] [Abstract][Full Text] [Related]
12. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.
Sanfilippo JS; Rao CV; Guarnaschelli JJ; Woost PG; Byrd VM; Jones E; Schultz GS
Surg Gynecol Obstet; 1993 Nov; 177(5):488-96. PubMed ID: 8211601
[TBL] [Abstract][Full Text] [Related]
13. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
Lössner D; Abou-Ajram C; Benge A; Reuning U
Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
16. EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors.
Minguillon C; Schönborn I; Reles A; Bartel U; Lichtenegger W
Gen Diagn Pathol; 1996 Mar; 141(3-4):197-201. PubMed ID: 8705783
[TBL] [Abstract][Full Text] [Related]
17. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor and its receptor gene expression and peptide localization in porcine ovarian follicles.
Singh B; Rutledge JM; Armstrong DT
Mol Reprod Dev; 1995 Apr; 40(4):391-9. PubMed ID: 7598904
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
20. A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer.
Owens OJ; Stewart C; Leake RE; McNicol AM
Anticancer Res; 1992; 12(5):1455-8. PubMed ID: 1444207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]